Status:
WITHDRAWN
A Research Study, Looking at How NovoMix® Works in People With Type 2 Diabetes in Local Clinical Practice in Algeria
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
19+ years
Brief Summary
The purpose of the study is to collect information about how NovoMix® 30 works in real world adult population with type 2 diabetes. Participants will get NovoMix® 30 as prescribed by the study doctor....
Eligibility Criteria
Inclusion
- Signed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol)
- The decision to initiate treatment with commercially available NovoMix® 30 has been made by the patient and the treating physician before and independently from the decision to include the patient in this study
- Male or female, greater than or equal to 19 years at the time of signing informed consent
- Diagnosed with type 2 diabetes and treated with basal insulin plus 1-3 bolus insulin injections per day for at least 24 weeks prior to informed consent
- Available and documented HbA1c value less than or equal to 12 weeks prior to initiation of NovoMix® 30 treatment
Exclusion
- Previous participation in this study. Participation is defined as having given informed consent in this study
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Participation in any clinical trial of an approved or non- approved investigational medicinal product within 24 weeks prior to initiation of NovoMix® 30 treatment. Clinical trials do not include non-interventional studies
- Hypersensitivity to NovoMix® 30 or to any of the excipients
- Pregnancy or intention of becoming pregnant
Key Trial Info
Start Date :
May 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 28 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03862690
Start Date
May 28 2020
End Date
June 28 2021
Last Update
July 20 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Algiers, Algeria, P.C. 16000, Hydra
2
Novo Nordisk Investigational Site
Constantine, Algeria, 25000